Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-23-005869

← back to feed
Filed
Aug 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 10, 2023 51.29M sh
Capex Q2 2023 · Jun 30, 2023 $0
Capex Q2 2023 · Jun 30, 2022 $31K
Cash And Equivalents Q2 2023 · Jun 30, 2023 $1.36M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $2.31M
Current Liabilities Q2 2023 · Jun 30, 2023 $4.94M
Current Liabilities Q2 2023 · Dec 31, 2022 $4.87M
Total Liabilities Q2 2023 · Jun 30, 2023 $5.66M
Total Liabilities Q2 2023 · Dec 31, 2022 $6.25M
Current Assets Q2 2023 · Jun 30, 2023 $2.03M
Current Assets Q2 2023 · Dec 31, 2022 $3M
Total Assets Q2 2023 · Jun 30, 2023 $2.35M
Total Assets Q2 2023 · Dec 31, 2022 $3.37M
Shares Diluted Q2 2023 · Jun 30, 2022 26.34M sh
Shares Diluted Q2 2023 · Jun 30, 2022 23.53M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$528K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$5.77M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$4.99M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$5.45M
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.04
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.09
Eps Basic Q2 2023 · Jun 30, 2022 −$0.04
Eps Basic Q2 2023 · Jun 30, 2022 −$0.09
Sga Expense Q2 2023 · Jun 30, 2022 $675K
Sga Expense Q2 2023 · Jun 30, 2022 $1.06M
Rd Expense Q2 2023 · Jun 30, 2022 $9K
Rd Expense Q2 2023 · Jun 30, 2022 $31K
Net Income Q2 2023 · Jun 30, 2022 −$926K
Net Income Q2 2023 · Jun 30, 2022 −$1.43M
Operating Income Q2 2023 · Jun 30, 2022 −$717K
Operating Income Q2 2023 · Jun 30, 2022 −$1.16M
Gross Profit Q2 2023 · Jun 30, 2022 $4K
Gross Profit Q2 2023 · Jun 30, 2022 $8K
Revenue Q2 2023 · Jun 30, 2022 $5K
Revenue Q2 2023 · Jun 30, 2022 $10K